These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9124369)
1. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K Am J Physiol; 1997 Feb; 272(2 Pt 1):L197-202. PubMed ID: 9124369 [TBL] [Abstract][Full Text] [Related]
2. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K Blood; 1996 Jan; 87(2):642-7. PubMed ID: 8555486 [TBL] [Abstract][Full Text] [Related]
3. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Mizutani A; Okajima K; Uchiba M; Noguchi T Blood; 2000 Jun; 95(12):3781-7. PubMed ID: 10845910 [TBL] [Abstract][Full Text] [Related]
4. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Hirose K; Okajima K; Taoka Y; Uchiba M; Tagami H; Nakano K; Utoh J; Okabe H; Kitamura N Ann Surg; 2000 Aug; 232(2):272-80. PubMed ID: 10903607 [TBL] [Abstract][Full Text] [Related]
5. Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Isobe H; Okajima K; Uchiba M; Mizutani A; Harada N; Nagasaki A; Okabe K Circulation; 2001 Sep; 104(10):1171-5. PubMed ID: 11535575 [TBL] [Abstract][Full Text] [Related]
6. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K Thromb Res; 1995 Apr; 78(2):117-25. PubMed ID: 7482429 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats. Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107 [TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation. Enkhbaatar P; Okajima K; Murakami K; Uchiba M; Okabe H; Okabe K; Yamaguchi Y Am J Respir Crit Care Med; 2000 Nov; 162(5):1752-9. PubMed ID: 11069808 [TBL] [Abstract][Full Text] [Related]
9. Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. Taoka Y; Okajima K; Uchiba M; Murakami K; Harada N; Johno M; Naruo M J Neurosci; 1998 Feb; 18(4):1393-8. PubMed ID: 9454848 [TBL] [Abstract][Full Text] [Related]
10. Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats. Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K Am J Respir Crit Care Med; 1997 Feb; 155(2):711-8. PubMed ID: 9032217 [TBL] [Abstract][Full Text] [Related]
11. Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats. Taoka Y; Okajima K; Uchiba M; Murakami K; Kushimoto S; Johno M; Naruo M; Okabe H; Takatsuki K Crit Care Med; 1997 May; 25(5):874-9. PubMed ID: 9187610 [TBL] [Abstract][Full Text] [Related]
12. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Yuksel M; Okajima K; Uchiba M; Horiuchi S; Okabe H Thromb Haemost; 2002 Aug; 88(2):267-73. PubMed ID: 12195699 [TBL] [Abstract][Full Text] [Related]
13. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III. Uchiba M; Okajima K Semin Thromb Hemost; 1997; 23(6):583-90. PubMed ID: 9469634 [TBL] [Abstract][Full Text] [Related]
14. Activated protein C reduces stress-induced gastric mucosal injury in rats by inhibiting the endothelial cell injury. Isobe H; Okajima K; Harada N; Liu W; Okabe H J Thromb Haemost; 2004 Feb; 2(2):313-20. PubMed ID: 14995995 [TBL] [Abstract][Full Text] [Related]
15. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation. Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K Am J Physiol; 1996 Sep; 271(3 Pt 1):L470-5. PubMed ID: 8843797 [TBL] [Abstract][Full Text] [Related]
16. The prevention of lipopolysaccharide-induced pulmonary vascular injury by pretreatment with cepharanthine in rats. Murakami K; Okajima K; Uchiba M Am J Respir Crit Care Med; 2000 Jan; 161(1):57-63. PubMed ID: 10619798 [TBL] [Abstract][Full Text] [Related]
17. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes. Murakami K; Okajima K; Uchiba M; Okabe H; Takatsuki K Crit Care Med; 1996 Jun; 24(6):1047-53. PubMed ID: 8681572 [TBL] [Abstract][Full Text] [Related]
18. Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats. Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K Am J Hematol; 1997 Feb; 54(2):118-23. PubMed ID: 9034285 [TBL] [Abstract][Full Text] [Related]
20. Pretreatment with activated protein C or active human urinary thrombomodulin attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion in rat liver. Yamaguchi Y; Hisama N; Okajima K; Uchiba M; Murakami K; Takahashi Y; Yamada S; Mori K; Ogawa M Hepatology; 1997 May; 25(5):1136-40. PubMed ID: 9141430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]